https://www.investors.com/news/technology/azn-stock-astrazeneca-earnings-q3-2023/
0
0
11/9/23 at 10:02pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
The company is licensing a new GLP-1 drug in the hopes of taking on Novo and Lilly.
Create an account
or login to join the discussion